Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for COVID-19
Paula Rossini Augusti, Greicy M. M. Conterato, Cristiane Casagrande Denardin, Inês Prazeres, Teresa Serra, Maria Rosário Bronze, Tatiana Emanuelli
Topics & Concepts
BioavailabilityCoronavirus disease 2019 (COVID-19)PneumoniaDrugGut floraImmune systemPharmacologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseAntioxidantBiotransformationBiologyMedicineImmunologyInfectious disease (medical specialty)BiochemistryEnzymeInternal medicineGut microbiota and healthTryptophan and brain disordersMedicinal Plants and Bioactive Compounds